Leonardo DRS, Inc. — Director's Dealing 2025

Mar 19, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Leonardo DRS, Inc. (DRS)
CIK: 0001833756
Period of Report: 2025-03-17

Reporting Person: Dorfman Mark (EVP, GC and Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-17	Common Stock	M	23949	—	Acquired	56380	Direct
2025-03-17	Common Stock	F	8080	$33.13	Disposed	48300	Direct
2025-03-17	Common Stock	M	22696	—	Acquired	70996	Direct
2025-03-17	Common Stock	F	10065	$33.13	Disposed	60931	Direct
2025-03-17	Common Stock	M	9457	—	Acquired	70388	Direct
2025-03-17	Common Stock	F	4568	$33.13	Disposed	65820	Direct
2025-03-18	Common Stock	S	20034	$32.69	Disposed	45786	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-17	Performance Restricted Stock Unit	$	M	23949	Disposed		Common Stock (23949)	Direct
2025-03-17	Performance Restricted Stock Unit	$	M	22696	Disposed		Common Stock (22696)	Direct
2025-03-17	Restricted Stock Unit	$	M	9457	Disposed		Common Stock (9457)	Direct

Footnotes

F1: Each performance restricted stock unit ("PRSU") was granted under the Issuer's 2022 Omnibus Equity Compensation Plan (the "Plan") and represents a contingent right to receive one share of the common stock of the Issuer or the cash equivalent thereof. The PRSUs were granted to the Reporting Person in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated June 21, 2022, by and among Leonardo DRS, Inc., RADA Electronic Industries Limited and Blackstart Ltd (the "Merger"). The PRSUs vested on March 17, 2025.

F2: Shares withheld by the Company to satisfy tax withholding requirements.

F3: Each restricted stock unit ("RSU") was granted under the Plan and represents a contingent right to receive one share of the common stock of the Issuer or the cash equivalent thereof. The final third of the RSUs vested on March 17, 2025.

F4: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2024.

F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.85 - $33.21, inclusive. The Reporting Person undertakes to provide upon request by the Commission staff, the Company or a security holder of the Company, full information regarding the number of shares sold at each separate price.